Metastatic lymph node in gastric cancer; Is it a real distant metastasis?

BMC Cancer

Table 2 Patients' characteristics according to primary sites

	Low & mid-body (n = 68)	High body & whole stomach (n = 11)	P value
Age (mean)	56.2	57.9	0.524
Sex			0.262
Male	44 (35.3%)	9 (81.8%)
Female	24 (64.7%)	2 (18.2%)
ECOG performance status			0.780
0	8 (11.8%)	2 (18.2%)
1	59 (86.8%)	9 (81.8%)
2	1 (1.5%)	0
Bormann type			0.033
I	0	0
II	16 (23.5%)	1 (9.1%)
III	46 (67.6%)	6 (54.5%)
IV	6 (8.8%)	4 (36.4%)
Lauren classification			0.527
Intestinal	17 (25.0%)	3 (23.7%)
Diffuse	31 (45.6%)	7 (63.6%)
Mixed	4 (5.9%)	0
Unknown	16 (23.5%)	1 (9.1%)
Histological grade			0.390
Well to moderate	21 (30.9%)	2 (18.2%)
Poor to undifferentiated	47 (69.1%)	9 (81.8%)
Type of gastrectomy			< 0.001
Total gastrectomy	26 (38.2%)	11 (100%)
Subtotal gastrectomy	42 (61.8%)	0
Extent of surgery			< 0.001
Resection of spleen	9 (13.2%)	6 (54.5%)
Resection of distal pancreas	2 (2.9%)	1 (9.1%)
Resection of spleen, pancreas	0	2 (18.2%)
T staging			0.543
T1	0	0
T2	27 (39.7%)	3 (27.3%)
T3	35 (51.5%)	6 (54.5%)
T4	6 (8.8%)	2 (18.2%)
N staging			0.066
N1	14 (20.6%)	0
N2	23 (33.8%)	2 (18.2%)
N3	31 (45.6%)	9 (81.8%)
No. of dissected LNs (mean)	43.3	52.8	0.157
Metastatic lymph node station			0.701
#12	59 (86.8%)	10 (90.9%)
#13	9 (13.2%)	1 (9.1%)
Post-operation treatment			0.553
None	17 (25.0%)	4 (36.4%)
Chemotherapy	41 (60.3%)	7 (63.6%)
Chemo-radiation	8 (11.8%)	0
Unknown	2 (2.9%)	0
Lymph node dissection			0.007
D2	67 (98.5%)	9 (81.8%)
D3	1 (1.5%)	2 (18.2%)

ISSN: 1471-2407